Results 151 to 160 of about 7,302 (251)

Causal effects of lipid-lowering drug targets on psychiatric disorders: A drug-target Mendelian randomization study. [PDF]

J Int Med Res
Wang Y, Liu X, Huang S.
europepmc   +1 more source

NPC1L1 as a Pharmacological Target of Hypercholesterolemia

MEMBRANE, 2008
Tappei Takada, Hiroshi Suzuki
openaire   +2 more sources

Mechanistic Insights into <i>Lactobacillus harbinensis</i> and Other Probiotics Regulating Lipid Metabolism in T2DM Mice via the PPARγ-LXRα-NPC1L1 Signaling Pathway Based on Multi-Omics Analysis. [PDF]

Metabolites
Yeerjiang B, Manaer T, Liu X, Bieerdimulati R, Nabi X.   +4 more
europepmc   +1 more source

Structure–activity relationship studies of Niemann-Pick type C1-like 1 (NPC1L1) ligands identified by screening assay monitoring pharmacological chaperone effect

, 2013
Fumika Karaki, Kenji Ohgane, Kosuke Dodo, Yuichi Hashimoto   +3 more
openalex   +1 more source

NPC1L1 (Niemann–Pick C1-like 1) mediates sterol-specific unidirectional transport of non-esterified cholesterol in McArdle-RH7777 hepatoma cells [PDF]

, 2007
J. Mark Brown, Lawrence L. Rudel, Liqing Yu   +2 more
openalex   +1 more source

Mutation on NPC1L1 NTD and the sterol binding stability: molecular dynamics study

, 2023
Hyejin Yoon, Yeeun Lee, Soonmin Jang, Jian Jeong, Gap‐Sue Kim, Hyung Ho Lee   +5 more
openalex   +1 more source

Mendelian randomization analysis of lipid-lowering drug targets and neuropsychiatric disorders. [PDF]

Medicine (Baltimore)
Peng S, Liu M, Du F, Li K.
europepmc   +1 more source

Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe‐mediated steatosis prevention and recovery [PDF]

, 2019
Yu Toyoda, Tappei Takada, Masakazu Umezawa, Fumiya Tomura, Yoshihide Yamanashi, Ken Takeda, Hiroshi Suzuki   +6 more
openalex   +1 more source

Marine Microalga <i>Tisochrysis lutea</i> F&M-M36 Modulates Gut Microbiota and Intestinal Cholesterol Transport Gene Expression in Association with Selected Early-Stage Metabolic Alterations Under High-Fat Feeding. [PDF]

Mar Drugs
Bigagli E, Meriggi N, D'Ambrosio M, Biondi N, Rodolfi L, Niccolai A, Bartolucci G, Menicatti M, de Filippo C, Luceri C.   +9 more
europepmc   +1 more source

Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events. [PDF]

Ann Med
Vuorio A, Kovanen PT, Strandberg T.
europepmc   +1 more source